Summary The present study examined the association between abortion prior to a first livebirth and breast cancer risk among a cohort of 3,315 women who had been delivered of liveborn children between 1946 and 1965 in a group of private gynaecology practices in Connecticut and followed through 1980 for the incidence of cancer. Among women with one livebirth at the time of cohort identification, a spontaneous abortion before this livebirth was associated with a 3.5-fold increase in the risk of breast cancer. The elevation in risk was independent of some of the major risk factors of breast cancer and became more pronounced as the number of years since the abortion increased.
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Although abortion has generally not been implicated as an important risk factor for breast cancer, a recent case-control study found a substantial increase in breast cancer risk among women who experienced a first trimester abortion prior to a first term pregnancy (Pike et al., 1981) . Of the two subsequent investigations examining this issue, the first found no association (Vessey et al., 1982) and the second, an increase in breast cancer risk only among women who had two or more short term pregnancies (less than 4 months gestation) before their first livebirth (Brinton et al., 1983) . Given this uncertainty, the following report will examine further the relationship between abortion before a first livebirth and risk of breast cancer.
Methods
The study uses data collected in the course of a retrospective cohort study to examine the association between exposure to exogenous oestrogens during pregnancy, particularly DES d, , and subsequent risk of cancer (Hadjimichael et al., 1984) . The cohort consisted of 3,315 Connecticut women who had been delivered of liveborn children in 1946-65 in a group of 11 obstetric and gynaecology practices located in Fairfield and New Haven counties in the state of Connecticut. These practices were selected on the basis of the physician's willingness to participate in the study, the number of records held since 1946 and the completeness of record keeping.
Since this was a study of the health effects of oestrogens, two groups of women qualified for the (Devesa et al., 1984) .
Incidence rates for breast cancer were based on ©) The Macmillan Press Ltd., 1986
person-years of follow-up. For women who developed breast cancer, person years were calculated up to the date of diagnosis. Cumulative incidence rates were calculated using standard survival analysis (Berkson, 1950) . The effects of possible confounding factors including age at menarche, age at first livebirth, age at diagnosis, parity, gravidity and exposure to exogenous oestrogens during pregnancy, were evaluated through the use of proportional hazards modelling (Cox et al., 1972 at menarche and oestrogen use during pregnancy; CAs described above, we were not able to determine when in the sequence of pregnancies the abortion or abortions had occurred.
exogenous oestrogens during pregnancy, the magnitude of risk, although reduced to 3.5, remained significantly elevated. In addition, when risk factors were evaluated individually, this elevation in breast cancer risk was evident regardless of the number of abortions a woman had before the first livebirth, whether or not she had been exposed to exogenous oestrogens during pregnancy, and irrespective of her age at the time of menarche or at the time of her first livebirth. The risk associated with ever having an abortion for the remainder of the cohort, that is women with two or more livebirths, is also presented in Table  II . Among this group an abortion did not increase the risk of breast cancer. whether or not they had an abortion before the livebirth. During the first 20 years of follow-up, there is only a slight elevation in the risk of breast cancer associated with abortion before a first livebirth. After 20 years the risk of breast cancer increases much more sharply among women with an abortion before a first livebirth compared to those without.
Because this cohort experienced breast cancer at a much later age than the women studied in the initial investigation suggesting the abortion association (Pike et al., 1981) , it was of interest to determine if the risk of breast cancer associated with spontaneous abortions varied with age at diagnosis. Although there were too few breast cancer cases diagnosed before the age of 40 (only 2) to allow for a stable estimate of risk, some difference was seen in the magnitude of risk among women diagnosed before age 50 (Rate ratio, RR=4.1; 95% Confidence interval, CI=1.5-11.3) and after age 50 (RR= 2.8; 95% CI=0.9-8.5).
Discussion From a cohort of women assembled to examine the effect of oestrogen therapy given during pregnancy on cancer risk, it was found that among women with one livebirth, a spontaneous abortion before this birth was associated with an adjusted 3.5-fold increase in the risk of breast cancer relative to women with no history of abortion. It was not possible to adjust for some of the known effect modifiers such as family history of breast cancer, benign breast disease, menopausal status and age at menopause. However, the elevation in risk was independent of some of the major risk factors of breast cancer, did not increase with the number of abortions occurring before the first livebirth and became more pronounced as the number of years since the abortion increased.
The present analysis was focused on women with one livebirth at the time of cohort identification. Among the remainder of the cohort, which included women with two or more livebirths, although the number of abortions was known, the dates of these events in relation to the livebirths was not. Among these women, an abortion was not associated with an increased risk of breast cancer. Since some of these abortions undoubtedly were the flrst pregnancy, if the observed association between abortion and breast cancer is real, the risk among women with two or more livebirths at the time of cohort identification should also be elevated, although less so than among the group with only one livebirth. One possible explanation for the absence of such a finding is suggested by the observation of Pike et al. (1981) that the breast cancer risk associated with abortion before the first livebirth was reduced among women who subsequently carried a pregnancy to term. Thus, in the present study, the risk among women with two or more livebirths may have been reduced because of these subsequent pregnancies. There may also be other factors associated with number of liveborn children that affect the possible links between abortion and breast cancer.
Experimental work with rats (Russo et al., 1980) suggests that pregnancy and lactation reduce the susceptibility of these animals to benign lesions and carcinomas by means of induction of full differentiation of the mammary gland. Russo et al. (1980) found that pregnancy interruption prevents sufficient differentiation in the gland to be protective. They reported that 77% of their experimental animals developed carcinomas and all of them developed benign lesions. The authors see a parallelism between the animal model and the human experience since in women during gestation there is increased secretion of oestrogen, progesterone and prolactin which together promote breast growth and differentiation. Abortion interrupts this process and leads to incomplete development of the mammary gland which may render it susceptible to carcinogenesis.
It is possible that the risk observed in this study reflects a bias introduced either in the seclection of the cohort or in its follow-up. Given that there was a similar percent of women with partial follow-up among those with a first pregnancy terminating in an abortion and those with no history of such an abortion, differential follow-up does not seem to be a likely alternative explanation. With regard to a bias introduced in the selection of the cohort, there is excellent agreement between the magnitude of breast cancer risk observed with the present cohort for oestrogen use during pregnancy compared to that found in another larger cohort (Greenberg et al., 1984) . The possibility of chance findings due to the small number of breast cancer cases cannot be ruled out.
In summary, these data indicate that an abortion prior to the first livebirth may increase a woman's risk of breast cancer. Whether this is the result of incomplete development of the mammary gland due to the interrupted pregnancy or of a hormonal imbalance that may result in both the spontaneous abortion and the cancer of the breast, or of some unsuspected factor, it is clear that further exploration of this issue is warranted.
